Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Found
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict65/ 100
Grade C · #207Found
An insurance-brokered GLP-1 marketplace whose $99/mo headline is the best of four different prices, unlocked only with both insurance and a 12-month prepay.
Visit FoundThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 65/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Found still earns its place — insured patients willing to prepay a year up front, or Medicare Part D members eligible for the time-limited $50/mo brand-name bridge program.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results68
92
Real-world results68
97Price honesty45
97
Price honesty45
96Prescriber access70
96
Prescriber access70
88Formulary choice88
88
Formulary choice88
95Cancellation fairness55
95
Cancellation fairness55
93Member support65
93
Member support65
Price, coverage & features
| Metric | CoreAge Rx | Found |
|---|---|---|
| Verdict Score | 94/100 | 65/100 |
| Grade | A | C |
| Semaglutide | $149/mo | From $99/mo with insurance (12-mo prepaid), $169/mo cash-pay (12-mo prepaid), $199/mo with insurance monthly, $289/mo cash-pay monthly |
| Tirzepatide | $349/mo | From $99/mo with insurance (12-mo prepaid), $169/mo cash-pay (12-mo prepaid), $199/mo with insurance monthly, $289/mo cash-pay monthly |
| Coverage | All 50 states | Most states (exact exclusion list not published) |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Found
What we like
- Genuinely broad formulary: compounded semaglutide and tirzepatide, four brand GLP-1s (Ozempic, Wegovy, Mounjaro, Zepbound) and the oral pill Foundayo (orforglipron), plus non-GLP-1 options like Contrave and metformin
- Real insurance brokering, not just a marketing claim — partners with Blue Cross, United Healthcare, Aetna, Cigna and Anthem, and most members reportedly pay under $30/visit
- A new Medicare GLP-1 Bridge program gets eligible Part D members brand Wegovy, Zepbound or Foundayo for a flat $50/mo copay
- Publishes molecule-specific outcome data with a methodology footnote (16% average loss on GLP-1 injections; 12.1% in 6 months on tirzepatide for treatment-naive members) rather than one generic number
The caveats
- The advertised $99/mo is a floor that requires insurance approval AND a 12-month prepaid commitment — without both, the real price is $169–$289/mo, up to 2.9x the headline
- Both molecules are priced as one undifferentiated "GLP-1 program" fee rather than a per-drug figure
- Brand-name self-pay is materially more expensive: Ozempic and Mounjaro run roughly $1,100/mo, Wegovy and Zepbound from $650/mo+
- The $50/mo Medicare copay is a named, time-limited bridge program (through December 2027), not a standing price
- No specific list of excluded states is published, only a generic disclaimer that coverage varies by state
- Compounded semaglutide and tirzepatide are not FDA-approved
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Insured patients willing to prepay a year up front, or Medicare Part D members eligible for the time-limited $50/mo brand-name bridge program.
Visit Found Read the full Found review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Found does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.